Exploring the Link Between Sleep Apnea and Cancer
Key Takeaways
-
OSA is associated with meaningfully higher cancer risk in observational research, with a relative risk of roughly 1.36 to 1.49 for cancer overall.¹
-
The risk isn't uniform across cancer types. Melanoma shows the strongest association (71% higher pooled risk), along with kidney cancer (HR 1.75) and bladder cancer (HR 1.76), while colorectal, breast, and prostate cancers show weaker or inconsistent associations.²
-
Intermittent hypoxia is the leading proposed mechanism, with mouse studies showing measurably increased tumor size, VEGF levels, and tumor-invasion markers under chronic intermittent hypoxia conditions.³
-
CPAP measurably improves certain immune markers linked to cancer surveillance, including a documented increase in natural killer T-cell frequency after 12 months of therapy, though this hasn't yet translated into a demonstrated reduction in cancer incidence in clinical trials.⁴
-
The strongest available trial evidence, a meta-analysis of three major RCTs, found no statistically significant reduction in cancer incidence among CPAP users compared to untreated controls.⁵
Quick answer: Observational studies link obstructive sleep apnea (OSA) to a higher risk of certain cancers, most strongly melanoma, kidney cancer, and pancreatic cancer, likely through intermittent hypoxia's effects on blood vessel growth, oxidative stress, and immune function. Randomized controlled trial evidence on whether CPAP therapy reduces cancer incidence has not shown a significant benefit. CPAP remains essential for its well-established cardiovascular and metabolic benefits, independent of the cancer question.
Which Cancers Are Linked to OSA, and How Strongly
The association between OSA and cancer risk isn't the same across cancer types. Research shows the strongest links with melanoma, kidney cancer, bladder cancer, and pancreatic cancer:
-
Melanoma shows the strongest pooled association, with OSA patients facing roughly a 71% higher relative risk.²
-
Kidney cancer (hazard ratio 1.75) and bladder cancer (hazard ratio 1.76) both show significant elevated risk in large cohort analyses.²
-
Pancreatic cancer also shows a significant association in nationwide health insurance database analyses.²
-
Colorectal, breast, and prostate cancers show weaker or inconsistent associations across studies, with some research finding no significant correlation or even a slightly lower observed risk in OSA patients for these specific cancer types.²
The Proposed Mechanism: Intermittent Hypoxia
During an apnea event, the airway partially or fully collapses, causing blood oxygen saturation to drop before a subsequent arousal restores normal breathing. Repeated overnight cycles of this kind, intermittent hypoxia, are the leading hypothesis for how OSA might influence cancer risk.
Angiogenesis. Intermittent hypoxia activates HIF-1α (hypoxia-inducible factor), a protein that drives the growth of new blood vessels and supports tumor invasion and metabolic reprogramming.³ A mouse model of lung cancer demonstrated this directly: animals exposed to chronic intermittent hypoxia developed significantly larger and more numerous tumors (9.14 vs. 5.71 average tumor count, 26.09 vs. 8.66 cm³ average volume) alongside significantly elevated VEGF levels and increased activity of MMP-2, an enzyme associated with tumor invasion and spread.³
Immune surveillance. OSA is associated with reduced circulating invariant natural killer T (iNKT) cells, immune cells involved in detecting and eliminating abnormal cells, and iNKT cell frequency correlates negatively with AHI and oxygen desaturation severity.⁴ Intermittent hypoxia also triggers TGF-β release, which suppresses natural killer cell and monocyte activity.⁴ Notably, one study found iNKT cell frequency increased following 12 months of CPAP therapy, suggesting treatment can partially restore this aspect of immune function even though it hasn't yet been shown to translate into lower cancer rates.⁴
What Clinical Trials Show About CPAP and Cancer Risk
A 2026 meta-analysis examined this question directly using data from three major randomized controlled trials, SAVE, RICCADSA, and ISAACC, comparing cancer incidence between OSA patients randomized to CPAP versus untreated controls. The result: no statistically significant difference in cancer incidence between the two groups.⁵ In the SAVE trial, cancer was reported in 3.1% of the CPAP group compared to 2.5% of the control group, not a significant difference.⁵
Randomized controlled trials carry more weight than observational cohort studies for this kind of question, since they can better account for other factors, like obesity, that commonly accompany OSA and might independently affect cancer risk. The current evidence suggests OSA is associated with elevated risk for specific cancers, and intermittent hypoxia offers a plausible biological explanation for why, but CPAP treatment hasn't yet been shown in trials to lower that risk.
Why Consistent CPAP Use Still Matters
CPAP therapy has strong, well-established evidence behind its cardiovascular and metabolic benefits: reduced blood pressure, lower stroke and heart disease risk, and improved daytime function.⁶ If you're managing a cancer diagnosis alongside sleep apnea, those benefits, particularly to energy levels, immune function, and quality of life during treatment, remain a solid, evidence-backed reason to stay consistent with therapy. For more on that specific overlap, see our post on sleep disorders and breast cancer.
Frequently Asked Questions
Does sleep apnea cause cancer?
No study shows direct causation. Observational research shows OSA is associated with higher risk for specific cancers, particularly melanoma, kidney, bladder, and pancreatic cancer, with intermittent hypoxia as the leading proposed mechanism.¹ ² ³
Does using CPAP reduce my cancer risk?
The strongest current evidence, a meta-analysis of three randomized controlled trials, found no significant difference in cancer incidence between CPAP users and untreated OSA patients. CPAP does measurably improve certain immune markers linked to cancer surveillance, but that hasn't yet been shown to translate into lower cancer rates in trials.⁴ ⁵
Which cancers are most strongly linked to sleep apnea?
Melanoma shows the strongest association, along with kidney, bladder, and pancreatic cancer. Colorectal, breast, and prostate cancers show weaker or inconsistent associations across studies.²
Should I be worried about my cancer risk if I have sleep apnea?
It's a reasonable topic to raise with your doctor rather than a cause for alarm on its own. The clearer, better-established reasons to treat OSA, cardiovascular, metabolic, and quality-of-life benefits, remain strong regardless of how the cancer research develops.
This article is for general informational purposes only and is not medical advice. If you have questions about sleep apnea, cancer risk, or your treatment plan, talk to your doctor or oncologist, who can advise you based on your specific health history.
If you suspect you have sleep apnea, a home sleep apnea test is a straightforward first step. The CPAP Shop offers CPAP machines, masks, and accessories to support consistent therapy. Call 866-414-9700 with any questions.
This post was updated on September 22, 2026.
References
-
"Obstructive Sleep Apnoea and the Incidence and Mortality of Cancer: A Meta-Analysis." pubmed.ncbi.nlm.nih.gov/26660307
-
"Causal Associations of Obstructive Sleep Apnea With Cancer Risk: A Mendelian Randomization Study." PMC. pmc.ncbi.nlm.nih.gov/articles/PMC12050956; "Obstructive Sleep Apnea and Incident Cancer: A Large Retrospective Multicenter Clinical Cohort Study." Cancer Epidemiology, Biomarkers & Prevention. aacrjournals.org/cebp/article/30/2/295
-
"Intermittent Hypoxia Exacerbates Tumor Progression in a Mouse Model of Lung Cancer." PMC. pmc.ncbi.nlm.nih.gov/articles/PMC7002457; "Hypoxia-Inducible Factor 1-Alpha (HIF-1α) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting." Cureus. cureus.com/articles/295248
-
"Advances in Immunology of Obstructive Sleep Apnea: Mechanistic Insights, Clinical Impact, and Therapeutic Perspectives." Frontiers in Immunology. pmc.ncbi.nlm.nih.gov/articles/PMC12582966
-
Theorell-Haglöw, J., et al. "CPAP to Reduce the Risk of Cancer in OSA?—A Meta-Analysis of 3 RCTs." Journal of Sleep Research, 2026. pmc.ncbi.nlm.nih.gov/articles/PMC13003302
-
American Heart Association. "Life's Essential 8." heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8
